1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Xu, B.
Hua, Q.-X.
Nakagawa, S.H.
Jia, W.
Chu, Y.-C.
Katsoyannis, P.G.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Protein Sci.
PRCIEI
0795
0961-8368
11
104
116
10.1110/ps.ps.32102
11742127
A cavity-forming mutation in insulin induces segmental unfolding of a surrounding alpha-helix.
2002
10.2210/pdb1k3m/pdb
pdb_00001k3m
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
2341.618
INSULIN
INSULIN A CHAIN (residues 90-110)
I2A
1
syn
polymer
3410.894
INSULIN
INSULIN B CHAIN (residues 25-54)
H10D, P28K, K29P
1
syn
polymer
no
no
GAVEQCCTSICSLYQLENYCN
GAVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGSDLVEALYLVCGERGFFYTKPT
FVNQHLCGSDLVEALYLVCGERGFFYTKPT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-10-17
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
HELIX
DETERMINATION METHOD: AUTHOR
RCSB
Y
RCSB
2001-10-03
REL
REL
The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human).
sample
The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human).
sample
This structure was determined using standard 2D homonuclear techniques.
structures with the lowest energy
60
15
2D NOESY
DQF-COSY
2D NOESY
DQF-COSY
2D NOESY
DQF-COSY
7.0
ambient
298
K
7.6
ambient
303
K
1.9
ambient
298
K
The structure is based on a total of 416 restraints, 367 are NOE-derived distance constraints, 32 dihedral angle restraints, 17 distance restraints from hydrogen bonds.
distance geometry and simulated annealing
1
closest to the average
1.2 mM AlaA2-DKP-Insulin; 100% D2O;
100% D2O
1.2 mM AlaA2-DKP-Insulin; 90% H2O, 10% D2O;
90% H2O/10% D2O
1.2 mM AlaA2-DKP-Insulin; 20% Deuteroacetic Acid, 80% D2O;
20% Deuteroacetic Acid, 80% D2O;
Brunger
refinement
X-PLOR
3.85
Molecular Simulations Inc.
refinement
DGII
InsightII 2000
Varian Inc.
processing
VNMR
6.1B
600
Varian
INOVA
GLY
1
n
1
GLY
1
A
ALA
2
n
2
ALA
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
ASP
10
n
10
ASP
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
LYS
28
n
28
LYS
28
B
PRO
29
n
29
PRO
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
O
H
LEU
CYS
15
19
1.26
2
B
B
O
H
LEU
CYS
15
19
1.28
2
B
B
O
H
CYS
LEU
7
11
1.47
2
A
B
H
O
ASN
GLY
21
23
1.50
3
B
B
O
H
LEU
CYS
15
19
1.39
3
B
B
O
H
CYS
LEU
7
11
1.45
3
A
A
O
HG1
CYS
THR
7
8
1.60
4
B
B
O
H
CYS
LEU
7
11
1.40
4
B
B
O
H
LEU
CYS
15
19
1.45
4
B
B
O
H
ALA
VAL
14
18
1.59
5
B
B
O
H
LEU
CYS
15
19
1.29
5
B
B
O
H
CYS
LEU
7
11
1.47
6
B
B
O
H
LEU
CYS
15
19
1.28
7
B
B
O
H
LEU
CYS
15
19
1.31
7
B
B
O
H
SER
VAL
9
12
1.56
8
B
B
O
H
LEU
CYS
15
19
1.49
8
B
B
O
H
GLY
VAL
8
12
1.58
8
B
B
O
H
ALA
VAL
14
18
1.59
9
B
B
O
H
CYS
LEU
7
11
1.42
9
B
B
O
H
LEU
CYS
15
19
1.46
9
B
B
O
H
ALA
VAL
14
18
1.52
9
A
A
O
H
TYR
GLU
14
17
1.58
10
B
B
O
H
LEU
CYS
15
19
1.52
10
B
B
O
H
ALA
VAL
14
18
1.52
11
B
B
O
H
LEU
CYS
15
19
1.32
12
B
B
O
H
LEU
CYS
15
19
1.27
12
B
B
O
H
CYS
LEU
7
11
1.43
12
A
A
O
H
CYS
SER
7
9
1.58
13
B
B
O
H
CYS
LEU
7
11
1.41
13
B
B
O
H
LEU
CYS
15
19
1.45
14
B
B
O
H
LEU
CYS
15
19
1.25
14
B
B
O
H
CYS
LEU
7
11
1.43
14
A
B
O
H
CYS
LEU
6
6
1.53
15
B
B
O
H
LEU
CYS
15
19
1.27
1
B
ARG
22
0.192
SIDE CHAIN
2
B
ARG
22
0.176
SIDE CHAIN
3
B
ARG
22
0.313
SIDE CHAIN
4
B
ARG
22
0.308
SIDE CHAIN
5
B
ARG
22
0.275
SIDE CHAIN
6
B
ARG
22
0.284
SIDE CHAIN
7
B
ARG
22
0.216
SIDE CHAIN
8
B
ARG
22
0.270
SIDE CHAIN
9
B
ARG
22
0.253
SIDE CHAIN
10
B
ARG
22
0.224
SIDE CHAIN
11
B
ARG
22
0.188
SIDE CHAIN
12
B
ARG
22
0.264
SIDE CHAIN
13
B
ARG
22
0.250
SIDE CHAIN
14
B
ARG
22
0.282
SIDE CHAIN
15
B
ARG
22
0.316
SIDE CHAIN
1
A
VAL
3
-122.64
-69.27
1
A
GLN
5
-163.14
60.57
1
A
CYS
6
160.00
-32.48
1
A
SER
9
164.97
-139.82
1
A
CYS
11
-78.77
-138.40
1
A
LEU
13
-37.36
-29.85
1
A
CYS
20
-74.41
-162.35
1
B
ASN
3
-177.35
138.16
1
B
HIS
5
65.90
120.89
2
A
VAL
3
-161.83
-62.85
2
A
SER
9
167.76
170.82
2
A
CYS
11
-73.65
-124.75
2
A
LEU
13
-32.74
-36.25
2
B
TYR
26
-86.60
49.92
2
B
LYS
28
55.38
78.52
3
A
ALA
2
-69.15
89.89
3
A
VAL
3
-133.65
-62.07
3
A
SER
9
163.23
-179.93
3
A
CYS
11
-59.25
-112.63
3
A
LEU
13
-35.90
-31.23
3
A
CYS
20
-104.60
-165.61
3
B
ASN
3
-159.24
54.19
3
B
GLN
4
-160.49
98.26
3
B
HIS
5
55.12
114.62
3
B
SER
9
-51.15
-71.94
3
B
GLU
21
81.72
-56.35
3
B
ARG
22
-54.13
176.65
4
A
ALA
2
-108.22
72.23
4
A
VAL
3
-167.56
-56.33
4
A
GLU
4
-60.30
-139.75
4
A
GLN
5
76.29
-76.30
4
A
SER
9
159.57
179.36
4
A
CYS
11
-61.36
-117.58
4
A
LEU
13
-35.25
-32.03
4
A
CYS
20
-129.46
-166.12
4
B
ASN
3
-112.16
58.56
4
B
GLN
4
-146.42
-72.33
4
B
ARG
22
-109.07
-100.68
4
B
LYS
28
-174.04
57.07
5
A
ALA
2
52.13
84.27
5
A
VAL
3
-95.67
-146.95
5
A
GLU
4
81.59
6.56
5
A
SER
9
164.35
-138.11
5
A
CYS
11
-53.15
-174.05
5
A
LEU
13
-29.75
-47.17
5
A
CYS
20
-126.74
-165.62
5
B
VAL
2
-139.58
-149.80
5
B
ASN
3
171.50
-172.62
5
B
GLN
4
-127.43
-141.48
6
A
ALA
2
72.99
87.52
6
A
VAL
3
-144.01
-41.27
6
A
GLN
5
-152.23
15.69
6
A
THR
8
-92.60
37.56
6
A
SER
9
158.41
-158.92
6
A
CYS
11
-62.32
-144.35
6
A
LEU
13
-35.27
-32.02
6
A
CYS
20
-126.80
-165.36
6
B
ASN
3
84.59
160.31
6
B
GLU
21
-149.11
19.87
6
B
TYR
26
-168.60
68.36
6
B
LYS
28
64.91
85.62
7
A
VAL
3
170.45
-92.18
7
A
GLU
4
-69.78
-150.94
7
A
GLN
5
78.30
37.98
7
A
CYS
6
-161.26
-52.05
7
A
THR
8
41.83
29.71
7
A
SER
9
171.58
-155.72
7
A
CYS
11
-69.57
-116.00
7
B
GLN
4
-120.28
-168.22
7
B
SER
9
-55.23
-77.91
7
B
GLU
21
85.09
-40.22
7
B
LYS
28
53.74
73.80
8
A
GLU
4
38.38
40.12
8
A
CYS
6
-153.83
17.63
8
A
SER
9
154.58
118.54
8
A
CYS
11
-60.00
-94.43
8
A
SER
12
-161.66
107.03
8
A
LEU
13
-34.92
-32.03
8
B
ASN
3
-115.65
-166.72
8
B
HIS
5
78.63
54.04
8
B
ARG
22
-72.58
-165.61
8
B
TYR
26
53.65
-77.37
8
B
THR
27
-95.37
-146.83
9
A
VAL
3
65.66
-71.99
9
A
GLN
5
-140.53
11.43
9
A
CYS
6
-159.75
-51.58
9
A
CYS
7
-51.48
-175.85
9
A
SER
9
160.66
-165.58
9
A
CYS
11
-63.19
-113.94
9
A
CYS
20
-102.31
-165.45
9
B
THR
27
-155.10
28.42
10
A
ALA
2
66.75
113.77
10
A
SER
9
159.10
145.48
10
A
CYS
11
-88.36
-120.53
10
A
LEU
13
-36.35
-32.58
10
B
VAL
2
-85.49
-153.99
10
B
ASN
3
-166.26
64.86
10
B
GLN
4
-120.13
-164.60
10
B
CYS
19
-82.94
46.13
10
B
GLU
21
79.34
-69.18
10
B
ARG
22
-4.79
-86.45
11
A
ALA
2
50.77
70.22
11
A
GLU
4
-62.28
85.94
11
A
GLN
5
-148.98
-39.27
11
A
THR
8
48.20
27.31
11
A
SER
9
164.61
172.64
11
A
CYS
11
-64.23
-117.58
11
A
LEU
13
-36.97
-31.15
11
A
CYS
20
-102.20
-167.74
11
B
SER
9
-51.96
-71.31
11
B
THR
27
-116.32
-165.22
12
A
ALA
2
163.30
-44.10
12
A
CYS
7
-65.37
-93.34
12
A
THR
8
-69.86
61.10
12
A
SER
9
164.05
148.65
12
A
CYS
11
-53.17
-100.37
12
A
LEU
13
-39.35
-28.24
12
B
GLN
4
-98.35
-144.46
12
B
HIS
5
-44.65
158.33
12
B
SER
9
-44.96
-71.09
13
A
ALA
2
73.16
40.91
13
A
SER
9
160.81
151.72
13
A
CYS
11
-63.64
-127.38
13
A
LEU
13
-36.74
-30.65
13
B
GLN
4
-122.17
-103.33
13
B
CYS
19
-70.46
49.13
13
B
THR
27
-147.08
-106.84
13
B
LYS
28
40.42
85.08
14
A
VAL
3
-154.69
-47.67
14
A
GLU
4
-106.92
58.65
14
A
SER
9
165.64
-139.42
14
A
CYS
11
-69.30
-112.17
14
A
SER
12
-160.99
118.69
14
A
CYS
20
-76.77
-161.74
14
B
VAL
2
-141.36
-153.10
14
B
ASN
3
-177.90
76.72
14
B
GLN
4
-143.62
-157.21
14
B
SER
9
-48.82
-70.75
14
B
CYS
19
-74.95
45.40
14
B
GLU
21
161.94
-23.75
14
B
TYR
26
-102.48
-163.55
14
B
THR
27
-79.42
-117.25
15
A
VAL
3
-163.68
-73.05
15
A
GLU
4
-54.58
103.04
15
A
GLN
5
160.70
-28.06
15
A
SER
9
173.14
-142.50
15
A
CYS
11
-61.79
-112.62
15
A
SER
12
-160.98
113.06
15
B
ASN
3
-148.61
47.78
15
B
GLN
4
-134.40
-51.73
15
B
GLU
21
83.87
-36.26
15
B
PHE
25
-99.27
50.77
15
B
TYR
26
-176.47
32.78
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
1
N
N
2
N
N
A
LEU
13
A
LEU
13
HELX_P
A
TYR
19
A
TYR
19
1
1
7
B
SER
9
B
SER
9
HELX_P
B
CYS
19
B
CYS
19
1
2
11
disulf
2.021
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.019
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.019
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE/GROWTH FACTOR
HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX
INS_HUMAN
UNP
1
90
P01308
GIVEQCCTSICSLYQLENYCN
INS_HUMAN
UNP
2
25
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
90
110
1K3M
1
21
P01308
A
1
1
21
25
54
1K3M
1
30
P01308
B
2
1
30
1
ILE
engineered mutation
ALA
2
1K3M
A
P01308
UNP
91
2
2
HIS
engineered mutation
ASP
10
1K3M
B
P01308
UNP
34
10
2
PRO
engineered mutation
LYS
28
1K3M
B
P01308
UNP
52
28
2
LYS
engineered mutation
PRO
29
1K3M
B
P01308
UNP
53
29